$JAZZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Jazz Pharmaceuticals plc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Jazz Pharmaceuticals plc. Get notifications about new insider transactions in Jazz Pharmaceuticals plc for free.
Page: < prev 1 ... 6 7 8 9 10 11 12 13 14 ... 14 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 16 2013 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 56.72 | 456 | 25,865 | 32,442 | 32.9 K to 32.4 K (-1.39 %) |
Jan 16 2013 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 56.72 | 22,772 | 1,291,669 | 1,618,300 | 1.6 M to 1.6 M (-1.39 %) |
Jan 14 2013 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 56.54 | 31 | 1,753 | 32,898 | 32.9 K to 32.9 K (-0.09 %) |
Jan 14 2013 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 56.54 | 1,569 | 88,710 | 1,641,072 | 1.6 M to 1.6 M (-0.10 %) |
Jan 11 2013 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 56.52 | 706 | 39,906 | 32,929 | 33.6 K to 32.9 K (-2.10 %) |
Jan 11 2013 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 56.52 | 35,216 | 1,990,563 | 1,642,641 | 1.7 M to 1.6 M (-2.10 %) |
Jan 11 2013 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 56.52 | 117 | 6,612 | 33,635 | 33.8 K to 33.6 K (-0.35 %) |
Jan 11 2013 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 56.52 | 5,783 | 326,834 | 1,677,857 | 1.7 M to 1.7 M (-0.34 %) |
Jan 10 2013 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 55.60 | 4,000 | 222,400 | 582,161 | 586.2 K to 582.2 K (-0.68 %) |
Dec 13 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 50.55 | 4,000 | 202,200 | 586,161 | 590.2 K to 586.2 K (-0.68 %) |
Nov 15 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 51.11 | 4,000 | 204,440 | 589,662 | 593.7 K to 589.7 K (-0.67 %) |
Oct 11 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 56.69 | 4,000 | 226,760 | 593,662 | 597.7 K to 593.7 K (-0.67 %) |
Oct 04 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 59.34 | 72 | 4,273 | 33,752 | 33.8 K to 33.8 K (-0.21 %) |
Oct 04 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 58.59 | 1,228 | 71,946 | 33,824 | 35.1 K to 33.8 K (-3.50 %) |
Oct 04 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 59.34 | 3,667 | 217,607 | 1,683,640 | 1.7 M to 1.7 M (-0.22 %) |
Oct 04 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 58.59 | 61,683 | 3,613,884 | 1,687,307 | 1.7 M to 1.7 M (-3.53 %) |
Oct 03 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Sell | S | 57.24 | 5,000 | 286,200 | 45,012 | 50 K to 45 K (-10.00 %) |
Aug 31 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 45.32 | 200,000 | 9,064,000 | 661,212 | 861.2 K to 661.2 K (-23.22 %) |
Aug 17 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | EVP and CFO | Sell | S | 47.57 | 53,000 | 2,521,210 | 0 | 53 K to 0 (-100.00 %) |
Aug 17 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | EVP and CFO | Sell | S | 47.48 | 7,000 | 332,360 | 88,782 | 95.8 K to 88.8 K (-7.31 %) |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | MOMTAZEE JAMES C | Director | Option Exercise | A | 46.83 | 4,500 | 210,735 | 4,500 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | MOMTAZEE JAMES C | Director | Grant | A | 0.00 | 2,250 | 0 | 16,135 | 13.9 K to 16.1 K (+16.20 %) |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Option Exercise | A | 46.83 | 4,500 | 210,735 | 4,500 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 2,250 | 0 | 39,907 | 37.7 K to 39.9 K (+5.97 %) |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Option Exercise | A | 46.83 | 8,000 | 374,640 | 8,000 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Sohn Catherine A. | Director | Grant | A | 0.00 | 4,000 | 0 | 4,000 | 0 to 4 K |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 46.83 | 4,500 | 210,735 | 4,500 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 46.83 | 4,500 | 210,735 | 4,500 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 46.83 | 4,500 | 210,735 | 4,500 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 2,250 | 0 | 2,250 | 0 to 2.3 K |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Option Exercise | A | 46.83 | 35,000 | 1,639,050 | 35,000 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Grant | A | 0.00 | 17,500 | 0 | 2,443,555 | 2.4 M to 2.4 M (+0.72 %) |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | VP, Finance & PAO | Option Exercise | A | 46.83 | 30,000 | 1,404,900 | 30,000 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | VP, Finance & PAO | Grant | A | 0.00 | 15,000 | 0 | 17,292 | 2.3 K to 17.3 K (+654.45 %) |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Option Exercise | A | 46.83 | 70,000 | 3,278,100 | 70,000 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Tobias Jeffrey K | EVP, Research & Dev ... | Grant | A | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Option Exercise | A | 46.83 | 9,000 | 421,470 | 9,000 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Keegan Fintan | EVP, Technical Oper ... | Grant | A | 0.00 | 4,500 | 0 | 12,586 | 8.1 K to 12.6 K (+55.65 %) |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Option Exercise | A | 46.83 | 70,000 | 3,278,100 | 70,000 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Hooper Suzanne Sawochka | EVP and General Cou ... | Grant | A | 0.00 | 35,000 | 0 | 35,000 | 0 to 35 K |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | A | 46.83 | 200,000 | 9,366,000 | 200,000 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Grant | A | 0.00 | 100,000 | 0 | 597,662 | 497.7 K to 597.7 K (+20.09 %) |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Option Exercise | A | 46.83 | 70,000 | 3,278,100 | 70,000 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Grant | A | 0.00 | 35,000 | 0 | 50,012 | 15 K to 50 K (+233.15 %) |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | EVP and CFO | Option Exercise | A | 46.83 | 70,000 | 3,278,100 | 70,000 | |
Aug 13 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | EVP and CFO | Grant | A | 0.00 | 35,000 | 0 | 95,782 | 60.8 K to 95.8 K (+57.58 %) |
Jun 04 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | EVP and CFO | Buy | J | 6.43 | 2,581 | 16,596 | 60,782 | 58.2 K to 60.8 K (+4.43 %) |
Jun 04 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Buy | J | 25.13 | 596 | 14,977 | 497,662 | 497.1 K to 497.7 K (+0.12 %) |
Jun 04 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Buy | J | 14.89 | 1,007 | 14,994 | 15,012 | 14 K to 15 K (+7.19 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | VP, Finance & PAO | Sell | S | 49.56 | 8,000 | 396,480 | 2,292 | 10.3 K to 2.3 K (-77.73 %) |
Mar 30 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | X | 7.37 | 91,975 | 677,856 | 0 | |
Mar 30 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Buy | X | 7.37 | 91,975 | 677,856 | 861,212 | 769.2 K to 861.2 K (+11.96 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | EVP & Chief Commerc ... | Sell | S | 49.56 | 5,000 | 247,800 | 14,005 | 19 K to 14 K (-26.31 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP and General Cou ... | Sell | S | 49.56 | 50,000 | 2,478,000 | 32,213 | 82.2 K to 32.2 K (-60.82 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | S | 49.56 | 50,000 | 2,478,000 | 497,066 | 547.1 K to 497.1 K (-9.14 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Sell | S | 49.56 | 31,166 | 1,544,587 | 54,355 | 85.5 K to 54.4 K (-36.44 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | KKR Fund Holdings L.P. | 10% Owner | Sell | S | 49.56 | 12,692 | 629,016 | 23,753 | 36.4 K to 23.8 K (-34.83 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | KKR Fund Holdings L.P. | 10% Owner | Sell | S | 49.56 | 2,987,308 | 148,050,984 | 6,919,193 | 9.9 M to 6.9 M (-30.16 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Sell | S | 49.56 | 39,200 | 1,942,752 | 0 | 39.2 K to 0 (-100.00 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | KKR JP III LLC | 10% Owner | Sell | S | 49.56 | 12,692 | 629,016 | 23,753 | 36.4 K to 23.8 K (-34.83 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | KKR JP III LLC | 10% Owner | Sell | S | 49.56 | 2,987,308 | 148,050,984 | 6,919,193 | 9.9 M to 6.9 M (-30.16 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Sell | S | 49.56 | 9,405 | 466,112 | 27,631 | 37 K to 27.6 K (-25.39 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Sell | S | 49.56 | 940,595 | 46,615,888 | 1,431,499 | 2.4 M to 1.4 M (-39.65 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Gift | G | 0.00 | 864,954 | 0 | 864,954 | 0 to 865 K |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Gift | G | 0.00 | 864,954 | 0 | 2,426,055 | 3.3 M to 2.4 M (-26.28 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | Mulligan Seamus | Director | Sell | S | 49.56 | 2,000,000 | 99,120,000 | 3,291,009 | 5.3 M to 3.3 M (-37.80 %) |
Feb 01 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Buy | J | 0.00 | 255 | 0 | 547,066 | 546.8 K to 547.1 K (+0.05 %) |
Mar 13 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | S | 49.56 | 600,000 | 29,736,000 | 769,237 | 1.4 M to 769.2 K (-43.82 %) |
Mar 09 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 49.56 | 21,615 | 1,071,239 | 35,052 | 56.7 K to 35.1 K (-38.14 %) |
Mar 09 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 49.56 | 1,078,400 | 53,445,504 | 1,748,990 | 2.8 M to 1.7 M (-38.14 %) |
Mar 09 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | S | 49.56 | 49,985 | 2,477,257 | 0 | 50 K to 0 (-100.00 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP and General Cou ... | Option Exercise | A | 11.48 | 14,961 | 171,752 | 14,961 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP and General Cou ... | Option Exercise | A | 1.25 | 2,229 | 2,786 | 2,229 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP and General Cou ... | Option Exercise | A | 7.96 | 3,752 | 29,866 | 3,752 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP and General Cou ... | Option Exercise | A | 19.37 | 11,579 | 224,285 | 11,579 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP and General Cou ... | Option Exercise | A | 45.27 | 4,845 | 219,333 | 4,845 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP and General Cou ... | Option Exercise | A | 30.18 | 4,845 | 146,222 | 4,845 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP and General Cou ... | Option Exercise | A | 15.09 | 14,538 | 219,378 | 14,538 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP and General Cou ... | Grant | A | 0.00 | 82,213 | 0 | 82,213 | 0 to 82.2 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | VP, Finance & PAO | Option Exercise | A | 27.46 | 13,007 | 357,172 | 13,007 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | VP, Finance & PAO | Grant | A | 0.00 | 10,292 | 0 | 10,292 | 0 to 10.3 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Option Exercise | A | 11.48 | 3,750 | 43,050 | 3,750 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Option Exercise | A | 7.35 | 54,420 | 399,987 | 54,420 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Grant | A | 0.00 | 53,000 | 0 | 53,000 | 0 to 53 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Grant | A | 0.00 | 58,201 | 0 | 58,201 | 0 to 58.2 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | A | 11.48 | 17,420 | 199,982 | 17,420 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | A | 1.25 | 182 | 228 | 182 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | A | 7.96 | 7,040 | 56,038 | 7,040 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | A | 19.37 | 12,583 | 243,733 | 12,583 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | A | 45.27 | 5,299 | 239,886 | 5,299 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | A | 30.18 | 5,299 | 159,924 | 5,299 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | A | 15.09 | 15,902 | 239,961 | 15,902 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Grant | A | 0.00 | 546,811 | 0 | 546,811 | 0 to 546.8 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Option Exercise | A | 8.23 | 45,200 | 371,996 | 45,200 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Grant | A | 0.00 | 19,005 | 0 | 19,005 | 0 to 19 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Grant | A | 0.00 | 37,657 | 0 | 37,657 | 0 to 37.7 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 7.37 | 91,975 | 677,856 | 91,975 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | A | 0.00 | 22,249 | 0 | 22,249 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Grant | A | 0.00 | 1,330,890 | 0 | 1,330,890 | 0 to 1.3 M |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Grant | A | 0.00 | 38,347 | 0 | 38,347 | 0 to 38.3 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Option Exercise | A | 0.00 | 16,079 | 0 | 16,079 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Grant | A | 0.00 | 85,521 | 0 | 85,521 | 0 to 85.5 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Grant | A | 0.00 | 35,635 | 0 | 35,635 | 0 to 35.6 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Grant | A | 0.00 | 2,282,247 | 0 | 2,282,247 | 0 to 2.3 M |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | CRESSEY BRYAN C | Director | Grant | A | 0.00 | 38,347 | 0 | 38,347 | 0 to 38.3 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 4.00 | 18,624 | 74,496 | 18,624 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 4.00 | 929,243 | 3,716,972 | 929,243 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | A | 0.00 | 9,929 | 0 | 9,929 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 56,667 | 0 | 56,667 | 0 to 56.7 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 2,827,390 | 0 | 2,827,390 | 0 to 2.8 M |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Grant | A | 0.00 | 49,985 | 0 | 49,985 | 0 to 50 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Option Exercise | A | 0.00 | 4,691 | 0 | 4,691 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | BERNS PAUL L | Director | Grant | A | 0.00 | 39,200 | 0 | 39,200 | 0 to 39.2 K |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | VP, Finance & PAO | Option Exercise | D | 27.46 | 13,007 | 357,172 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | WILSON KAREN J | VP, Finance & PAO | Sell | D | 0.00 | 10,292 | 0 | 0 | 10.3 K to 0 (-100.00 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Option Exercise | D | 11.48 | 14,961 | 171,752 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Option Exercise | D | 1.25 | 2,229 | 2,786 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Option Exercise | D | 7.96 | 3,752 | 29,866 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Option Exercise | D | 19.37 | 11,579 | 224,285 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Option Exercise | D | 45.27 | 4,845 | 219,333 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Option Exercise | D | 30.18 | 4,845 | 146,222 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Option Exercise | D | 15.09 | 14,538 | 219,378 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Gamble Carol A | SVP, GC and Secreta ... | Sell | D | 0.00 | 82,213 | 0 | 0 | 82.2 K to 0 (-100.00 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Option Exercise | D | 11.48 | 3,750 | 43,050 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Option Exercise | D | 7.35 | 54,420 | 399,987 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Sell | D | 0.00 | 53,000 | 0 | 0 | 53 K to 0 (-100.00 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | FALBERG KATHRYN E | SVP and CFO | Sell | D | 0.00 | 58,201 | 0 | 0 | 58.2 K to 0 (-100.00 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | D | 11.48 | 17,420 | 199,982 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | D | 1.25 | 182 | 228 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | D | 7.96 | 7,040 | 56,038 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | D | 19.37 | 12,583 | 243,733 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | D | 45.27 | 5,299 | 239,886 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | D | 30.18 | 5,299 | 159,924 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Option Exercise | D | 15.09 | 15,902 | 239,961 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | COZADD BRUCE C | Chairman and CEO | Sell | D | 0.00 | 546,811 | 0 | 0 | 546.8 K to 0 (-100.00 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Winningham Rick E | Director | Sell | D | 0.00 | 37,657 | 0 | 0 | 37.7 K to 0 (-100.00 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Option Exercise | D | 0.00 | 16,079 | 0 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | SEBULSKY ALAN | Director | Sell | D | 0.00 | 85,521 | 0 | 0 | 85.5 K to 0 (-100.00 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Option Exercise | D | 8.23 | 45,200 | 371,996 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | Cox Russell J. | SVP, Sales and Mark ... | Sell | D | 0.00 | 19,005 | 0 | 0 | 19 K to 0 (-100.00 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | D | 7.37 | 91,975 | 677,856 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Option Exercise | D | 0.00 | 22,249 | 0 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | D | 0.00 | 1,330,890 | 0 | 0 | 1.3 M to 0 (-100.00 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | O'Keefe Kenneth W | Director | Sell | D | 0.00 | 38,347 | 0 | 0 | 38.3 K to 0 (-100.00 %) |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 4.00 | 18,624 | 74,496 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 4.00 | 929,243 | 3,716,972 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Option Exercise | D | 0.00 | 9,929 | 0 | 0 | |
Jan 18 2012 | JAZZ | Jazz Pharmaceutica ... | ENRIGHT PATRICK G | Director | Sell | D | 0.00 | 56,667 | 0 | 0 | 56.7 K to 0 (-100.00 %) |